EPRX
Price
$3.29
Change
+$0.12 (+3.79%)
Updated
Apr 17 closing price
Capitalization
117.1M
19 days until earnings call
RCKT
Price
$6.33
Change
+$0.18 (+2.93%)
Updated
Apr 17 closing price
Capitalization
674.97M
23 days until earnings call
Ad is loading...

EPRX vs RCKT

Header iconEPRX vs RCKT Comparison
Open Charts EPRX vs RCKTBanner chart's image
Eupraxia Pharmaceuticals
Price$3.29
Change+$0.12 (+3.79%)
Volume$6.85K
Capitalization117.1M
Rocket Pharmaceuticals
Price$6.33
Change+$0.18 (+2.93%)
Volume$2.2M
Capitalization674.97M
EPRX vs RCKT Comparison Chart
Loading...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EPRX vs. RCKT commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPRX is a Hold and RCKT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (EPRX: $3.29 vs. RCKT: $6.33)
Brand notoriety: EPRX and RCKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EPRX: 40% vs. RCKT: 89%
Market capitalization -- EPRX: $117.1M vs. RCKT: $674.97M
EPRX [@Biotechnology] is valued at $117.1M. RCKT’s [@Biotechnology] market capitalization is $674.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EPRX’s FA Score shows that 0 FA rating(s) are green whileRCKT’s FA Score has 1 green FA rating(s).

  • EPRX’s FA Score: 0 green, 5 red.
  • RCKT’s FA Score: 1 green, 4 red.
According to our system of comparison, RCKT is a better buy in the long-term than EPRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EPRX’s TA Score shows that 5 TA indicator(s) are bullish while RCKT’s TA Score has 5 bullish TA indicator(s).

  • EPRX’s TA Score: 5 bullish, 5 bearish.
  • RCKT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RCKT is a better buy in the short-term than EPRX.

Price Growth

EPRX (@Biotechnology) experienced а +8.58% price change this week, while RCKT (@Biotechnology) price change was +28.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was -13.21%, and the average quarterly price growth was -24.46%.

Reported Earning Dates

EPRX is expected to report earnings on Aug 08, 2025.

RCKT is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCKT($675M) has a higher market cap than EPRX($117M). EPRX YTD gains are higher at: 3.785 vs. RCKT (-49.642). EPRX has higher annual earnings (EBITDA): -27.76M vs. RCKT (-247.48M). RCKT has more cash in the bank: 372M vs. EPRX (8.66M). EPRX has less debt than RCKT: EPRX (93K) vs RCKT (25.5M). EPRX (0) and RCKT (0) have equivalent revenues.
EPRXRCKTEPRX / RCKT
Capitalization117M675M17%
EBITDA-27.76M-247.48M11%
Gain YTD3.785-49.642-8%
P/E RatioN/AN/A-
Revenue00-
Total Cash8.66M372M2%
Total Debt93K25.5M0%
FUNDAMENTALS RATINGS
RCKT: Fundamental Ratings
RCKT
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EPRXRCKT
RSI
ODDS (%)
Bullish Trend 3 days ago
30%
Bullish Trend 3 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
56%
Bullish Trend 3 days ago
88%
MACD
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
39%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
56%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
80%
Bearish Trend 16 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
78%
Aroon
ODDS (%)
Bearish Trend 3 days ago
37%
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GABSX38.520.37
+0.97%
Gabelli Small Cap Growth AAA
WQAUX10.870.05
+0.46%
Westwood Quality AllCap Ultra
KTRIX8.40-0.01
-0.12%
DWS Global Income Builder Inst
BRLGX28.69-0.06
-0.21%
American Beacon Man Lg Cp Growth R5
JATIX54.51-0.36
-0.66%
Janus Henderson Glb Tech and Innovt I

EPRX and

Correlation & Price change

A.I.dvisor tells us that EPRX and CCCC have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EPRX and CCCC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
+3.79%
CCCC - EPRX
29%
Poorly correlated
+13.64%
ETNB - EPRX
29%
Poorly correlated
+2.89%
ACAD - EPRX
28%
Poorly correlated
+1.10%
FDMT - EPRX
26%
Poorly correlated
+5.15%
RCKT - EPRX
26%
Poorly correlated
+2.93%
More

RCKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCKT has been loosely correlated with RGNX. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if RCKT jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCKT
1D Price
Change %
RCKT100%
+2.93%
RGNX - RCKT
59%
Loosely correlated
-3.57%
DNLI - RCKT
59%
Loosely correlated
+1.51%
NTLA - RCKT
58%
Loosely correlated
+5.39%
ETNB - RCKT
57%
Loosely correlated
+2.89%
ACLX - RCKT
56%
Loosely correlated
+2.19%
More